Core Technology
Veterinary Vaccine Adjuvant
Country Best have successfully produced a wide range of veterinary vaccine adjuvant products for our customers. This is contributed by professional research teams emphasizing on veterinary, biochemistry, colloidal science and other related fields. Our core technology is based on polymer, emulsification as well as protein-like materials encapsulation technology systems, and we are proud to apply our core techniques to develop adjuvants with high safety, efficacy, stability, controllable release, highly efficient immunity. From concept and design to full scale production, we create innovative, reliable colloidal technology to make the adjuvant product serving for variety needs. Our core adjuvant technology includes:
Emulsion Technology
Emulsion type adjuvants including water-in-oil (W/O) or oil-in-water (O/W) emulsions suffer a range of disadvantages from emulsification to mixing ratios leading to instability or low vaccine efficacy. Our novel HLB technology maximizes the O/W type adjuvant stability on a wide range of mixing ratios that does not require sophisticated homogenizer or temperature control, saving time and cost. In addition, our O/W emulsion adjuvant can be easily sterilized through membrane filtration, ensuring your vaccine product with successfully sterilizing validation.
Polymer technology
Adjuvant without oil or with very low oil content always cause difficulties for inducing early immune response and long-lasting antibody titers. Our unique polymer technology comprises of biodegradable polymers formula that appear to have an excellent adjuvant effect on microencapsulated protein-like antigen, caused by its controlled release and/or immune stimulation of the dendritic cells by the polymer.
Dispersion and encapsulation technology
The dispersion technology we have been developing increases the solubility of bulk antigen when mixed our adjuvant, maximizing the adsorption and/or encapsulation efficiency of antigen to achieve the required immune response.
Our Core
Our core technologists provide a full adjuvant application, helping you select the most suitable adjuvant and working with you to develop the ideal properties your vaccine product requires, through to providing technical information and formulation assistance, and finally scaling up!
